<DOC>
	<DOC>NCT02838381</DOC>
	<brief_summary>The aim of this study is to characterize the genetic and cellular immunological parameters of metastatic digestive cancer patients having short and long responses to chemotherapy.</brief_summary>
	<brief_title>Study of Genetic and Cellular Immunological Parameters Predictive of Disease-free Survival in Patients With Metastatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Second Primary</mesh_term>
	<criteria>For all patients: signed written informed consent For cohort A: patient with metastatic colorectal cancer with firstline therapy by chemotherapy +/ surgery and with a diseasefree survival &gt; or = at 20 months Ctscan realized in the previous 4 weeks and showing no progression according to the Recist criteria v1.1 For cohort B: patient treated for metastatic colorectal cancer and chemotherapy responder (obtention of an objective response according to the Recist criteria V1.1 in firstline therapy), with a diseasefree survival &lt; 10 months (disease progression must be confirmed by CT scan evaluation according to Recist v1.1 criteria) For cohort C: patients with no metastatic rectum cancer in complete remission after chemotherapy and/or radiotherapy For cohort D: patients with metastatic or locally advanced cancer in complete remission after treatment, non eligible in the other cohorts For all patients: patient with any medical or psychiatric condition or disease which would make the patient inappropriate for entry into this study patient with a neurodegenerative disease patient under guardianship, curator or under the protection of justice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>